ArticleBMJ open2022

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study.

Mohammad Tasavon Gholamhoseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.